David P. Rosenbaum Insider Trading $ARDX ARDELYX, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David P. Rosenbaum.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David P. Rosenbaum. David P. Rosenbaum is Chief Development Officer in ARDELYX, INC. ($ARDX) and SVP, Drug Development in ARDELYX, INC. ($ARDX).
David P. Rosenbaum in ARDELYX, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David P. Rosenbaum: Chief Development Officer, SVP, Drug Development
Holdings: 160,047 shares
Current Value: $1,768,519
Latest Transaction: Apr 08 2021
$ARDX Market Capitalization: $529.77M
$ARDX Previous Close: $11.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David P. Rosenbaum in ARDELYX, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 08 2021 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Sell | S | 8.00 | 5,000 | 40,000 | 160,047 | 165 K to 160 K (-3.03 %) |
| Feb 24 2021 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Sell | S | 6.88 | 193 | 1,328 | 29,969 | 30.2 K to 30 K (-0.64 %) |
| Feb 24 2021 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Sell | S | 6.88 | 612 | 4,212 | 165,047 | 165.7 K to 165 K (-0.37 %) |
| Feb 24 2021 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Sell | S | 6.88 | 193 | 1,328 | 29,969 | 30.2 K to 30 K (-0.64 %) |
| Feb 24 2021 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Sell | S | 6.88 | 612 | 4,212 | 165,047 | 165.7 K to 165 K (-0.37 %) |
| Jan 07 2021 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Option Exercise | A | 6.35 | 37,500 | 238,125 | 37,500 | |
| Jan 07 2021 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Option Exercise | A | 6.35 | 146,755 | 931,894 | 146,755 | |
| Jan 07 2021 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Grant | A | 0.00 | 8,500 | 0 | 30,162 | 21.7 K to 30.2 K (+39.24 %) |
| Jan 07 2021 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Grant | A | 0.00 | 32,612 | 0 | 165,659 | 133 K to 165.7 K (+24.51 %) |
| Sep 17 2020 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Sell | S | 5.51 | 3,470 | 19,131 | 21,662 | 25.1 K to 21.7 K (-13.81 %) |
| Sep 17 2020 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Sell | S | 5.52 | 34,656 | 191,301 | 133,047 | 167.7 K to 133 K (-20.67 %) |
| Feb 20 2020 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Option Exercise | A | 7.17 | 47,500 | 340,575 | 47,500 | |
| Jan 13 2020 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Option Exercise | A | 7.60 | 139,365 | 1,059,174 | 139,365 | |
| Jun 06 2019 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Sell | S | 2.54 | 2,856 | 7,258 | 160,171 | 163 K to 160.2 K (-1.75 %) |
| Jan 22 2019 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Option Exercise | A | 2.32 | 54,343 | 126,076 | 54,343 | |
| Jan 22 2019 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Option Exercise | A | 2.32 | 120,000 | 278,400 | 120,000 | |
| Jan 04 2019 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Sell | S | 1.70 | 801 | 1,363 | 18,029 | 18.8 K to 18 K (-4.25 %) |
| Jan 04 2019 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Sell | S | 1.70 | 5,585 | 9,503 | 160,027 | 165.6 K to 160 K (-3.37 %) |
| Nov 15 2018 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Sell | S | 2.84 | 5,570 | 15,819 | 165,612 | 171.2 K to 165.6 K (-3.25 %) |
| Jul 30 2018 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Option Exercise | A | 4.30 | 8,220 | 35,346 | 8,220 | |
| Jul 30 2018 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Option Exercise | A | 4.30 | 54,730 | 235,339 | 54,730 | |
| Jul 30 2018 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Grant | A | 0.00 | 10,000 | 0 | 17,045 | 7 K to 17 K (+141.94 %) |
| Jul 30 2018 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Grant | A | 0.00 | 100,000 | 0 | 168,555 | 68.6 K to 168.6 K (+145.87 %) |
| Jan 18 2018 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Option Exercise | A | 7.10 | 16,440 | 116,724 | 16,440 | |
| Jan 18 2018 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Option Exercise | A | 7.10 | 117,104 | 831,438 | 117,104 | |
| Aug 11 2017 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Option Exercise | A | 4.70 | 26,512 | 124,606 | 26,512 | |
| Aug 11 2017 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Grant | A | 0.00 | 26,512 | 0 | 66,641 | 40.1 K to 66.6 K (+66.07 %) |
| Apr 21 2017 | ARDX | ARDELYX, INC. | Rosenbaum David P. | Chief Development O ... | Sell | S | 11.98 | 2,051 | 24,577 | 40,129 | 42.2 K to 40.1 K (-4.86 %) |
| Mar 14 2017 | ARDX | ARDELYX, INC. | Rosenbaum David P. | SVP, Drug Developme ... | Sell | S | 13.48 | 1,000 | 13,482 | 1,277 | 2.3 K to 1.3 K (-43.92 %) |
| Jan 23 2017 | ARDX | ARDELYX, INC. | Rosenbaum David P. | SVP, Drug Developme ... | Option Exercise | A | 13.90 | 106,047 | 1,474,053 | 106,047 | |
| Jan 23 2017 | ARDX | ARDELYX, INC. | Rosenbaum David P. | SVP, Drug Developme ... | Grant | A | 0.00 | 17,985 | 0 | 40,129 | 22.1 K to 40.1 K (+81.22 %) |
| Dec 20 2016 | ARDX | ARDELYX, INC. | Rosenbaum David P. | SVP, Drug Developme ... | Sell | S | 14.48 | 900 | 13,035 | 636 | 1.5 K to 636 (-58.59 %) |
| Mar 07 2016 | ARDX | ARDELYX, INC. | Rosenbaum David P. | SVP, Drug Developme ... | Sell | S | 10.74 | 1,128 | 12,110 | 22,144 | 23.3 K to 22.1 K (-4.85 %) |
| Jan 20 2016 | ARDX | ARDELYX, INC. | Rosenbaum David P. | SVP, Drug Developme ... | Option Exercise | A | 10.55 | 90,377 | 953,477 | 90,377 | |
| Sep 23 2015 | ARDX | ARDELYX, INC. | Rosenbaum David P. | SVP, Drug Developme ... | Sell | S | 22.00 | 600 | 13,200 | 73,652 | 74.3 K to 73.7 K (-0.81 %) |
| Sep 23 2015 | ARDX | ARDELYX, INC. | Rosenbaum David P. | SVP, Drug Developme ... | Sell | S | 22.09 | 800 | 17,674 | 74,252 | 75.1 K to 74.3 K (-1.07 %) |
| Sep 17 2015 | ARDX | ARDELYX, INC. | Rosenbaum David P. | SVP, Drug Developme ... | Sell | S | 22.01 | 2,540 | 55,898 | 75,052 | 77.6 K to 75.1 K (-3.27 %) |
| Sep 03 2015 | ARDX | ARDELYX, INC. | Rosenbaum David P. | SVP, Drug Developme ... | Sell | S | 19.25 | 1,251 | 24,082 | 25,880 | 27.1 K to 25.9 K (-4.61 %) |
| Sep 03 2015 | ARDX | ARDELYX, INC. | Rosenbaum David P. | SVP, Drug Developme ... | Sell | S | 18.32 | 1,286 | 23,560 | 0 | 1.3 K to 0 (-100.00 %) |
| Aug 03 2015 | ARDX | ARDELYX, INC. | Rosenbaum David P. | SVP, Drug Developme ... | Sell | S | 19.27 | 2,011 | 38,755 | 75,581 | 77.6 K to 75.6 K (-2.59 %) |
Page: 1